Pheburane sodium phenylbutyrate regulatory update

The Medunik Canada subsidiary of Le Groupe Pharmaceutique Boivin (Montreal, Quebec) said Health Canada approved Pheburane sodium phenylbutyrate as adjunctive therapy in the chronic management of urea...